---
title: USJCMSP 2024 EID
---

- [Grants & Procurement](https://www.crdfglobal.org/grants-procurement/)
- [Contact Us](https://www.crdfglobal.org/contact-us/)

[Facebook](https://www.facebook.com/CRDFGlobal) <https://twitter.com/CRDFGlobal> [Instagram](https://www.instagram.com/crdfglobal/)[Linkedin](https://www.linkedin.com/company/crdf-global)

[![](https://insights.crdfglobal.org/hubfs/crdf-logo.svg)](https://crdfglobal.org/)

- WHO WE ARE
  
  #### [Our Story](https://crdfglobal.org/our-story/)
  
  #### [Mission, Vision & Values](https://crdfglobal.org/mission-vision-values/)
  
  #### [Leadership](https://crdfglobal.org/leadership)
  
  #### [Our Experts](https://crdfglobal.org/experts)
  
  #### [Clients & Partners](https://crdfglobal.org/partners)

  ![Who we are mega menu](https://www.crdfglobal.org/wp-content/uploads/2022/06/who-we-are-menu.jpg)
  
  More than 30 years advancing international security, technology, and economic progress in over 120 countries.
- WHAT WE DO
  
  #### [Chemical, Biological & Nuclear Security](https://www.crdfglobal.org/what-we-do/cbrne-security-counterproliferation/)
  
  #### [Cybersecurity & Digital Resilience](https://www.crdfglobal.org/what-we-do/cybersecurity/)
  
  #### [Research, Data & Emerging Technology Security](https://www.crdfglobal.org/what-we-do/research-data-and-technology-security/)

  #### [Security Cooperation & Exchanges](https://www.crdfglobal.org/what-we-do/international-exchanges/)
  
  #### [Border Security & Strategic Trade Controls](https://www.crdfglobal.org/what-we-do/strategic-trade-border-security/)
  
  #### [Health Security and Research](https://www.crdfglobal.org/what-we-do/global-health/)

  ![What we do mega menu](https://www.crdfglobal.org/wp-content/uploads/2022/07/MegaMenu_Website_Images_Ratios_SizesWhat-We-Do-Mega-Menu.png)
  
  Addressing evolving security and prosperity challenges through strategically tailored solutions.
- HOW WE DELIVER
  
  ### CORE CAPABILITIES
  
  #### [Travel & Logistics](https://crdfglobal.org/capabilities/travel-logistics/)
  
  #### [Specialized Equipment Procurement](https://crdfglobal.org/capabilities/specialized-equipment-procurement/)
  
  #### [Technical & Professional Trainings](https://crdfglobal.org/capabilities/technical-and-professional-trainings/)
  
  #### [Fellowships & Exchanges](https://crdfglobal.org/capabilities/fellowships-and-exchanges/)
  
  #### [Grants & Research Competitions](https://crdfglobal.org/capabilities/grants-research-competitions/)
  
  #### [Security Strengthening](https://crdfglobal.org/capabilities/security-strengthening/)

  ### INTEGRATED SOLUTIONS
  
  #### [Program Design and Management](https://crdfglobal.org/integrated-solutions/program-design-and-management/)
  
  #### [Quality Framework](https://crdfglobal.org/integrated-solutions/quality-framework/)
  
  #### [Monitoring, Evaluation and Learning](https://crdfglobal.org/integrated-solutions/monitoring-evaluation-and-learning/)
  
  #### [Remote Training & Learning](https://crdfglobal.org/integrated-solutions/remote-training-and-learning/)

  ![How we deliver mega menu](https://www.crdfglobal.org/wp-content/uploads/2022/01/how-we-deliver-menu-v2.jpg)
  
  Recognized leader in global program delivery, combining technical expertise with flexible, locally driven solutions.
- [WHERE WE WORK](https://crdfglobal.org/where-we-work/)
- [NEWS & INSIGHTS](https://www.crdfglobal.org/news/)
- [CAREERS](https://crdfglobal.org/careers/)

- [\> Home](https://insights.crdfglobal.org/usjcmspeid2024)
- [\> General Registration](https://insights.crdfglobal.org/usjcmspeid2024-1)
- [\> Speaker Registration](https://insights.crdfglobal.org/usjcmspeid2024-1-1)
- [\> Plenary Agenda](https://insights.crdfglobal.org/usjcmspeid2024-agenda)
- [\> Panel Agendas](https://insights.crdfglobal.org/usjcmspeid2024panels)
- [\> Travel Information](https://insights.crdfglobal.org/usjcmspeid2024-travel)
- [\> IDRIC Symposium](https://idric.kr/)
- [\> Abstract eBooks](https://insights.crdfglobal.org/usjcmspeid2024_ebooks)

---

![USJCMSP logo5 title](https://insights.crdfglobal.org/hs-fs/hubfs/USJCMSP%20logo5%20title.jpg?width=300&height=179&name=USJCMSP%20logo5%20title.jpg "USJCMSP logo5 title")

## The Joint 24th International Conference on Emerging Infectious Diseases in the Pacific Rim of the U.S.-Japan Cooperative Medical Sciences Program (USJCMSP) in collaboration with the 2nd International Symposium for Infectious Diseases Research Institutes Cooperation (IDRIC)

![logo1 (003)](https://insights.crdfglobal.org/hs-fs/hubfs/logo1%20(003).png?width=125&height=125&name=logo1%20(003).png "logo1 (003)")

![NIH\_Master\_Logo\_Vertical\_2Color-PNG (002)](https://insights.crdfglobal.org/hs-fs/hubfs/NIH_Master_Logo_Vertical_2Color-PNG%20(002).png?width=125&height=110&name=NIH_Master_Logo_Vertical_2Color-PNG%20(002).png "NIH_Master_Logo_Vertical_2Color-PNG (002)")

![KDCA\_KNIH\_KNIID LOGO change](https://insights.crdfglobal.org/hs-fs/hubfs/KDCA_KNIH_KNIID%20LOGO%20change.jpg?width=350&height=58&name=KDCA_KNIH_KNIID%20LOGO%20change.jpg "KDCA_KNIH_KNIID LOGO change")

![IVI\_logo (002)-1](https://insights.crdfglobal.org/hs-fs/hubfs/IVI_logo%20(002)-1.png?width=250&name=IVI_logo%20(002)-1.png "IVI_logo (002)-1")

Disclaimer: The views expressed in written conference materials or publications and by speakers and moderators at HHS-sponsored conferences do not necessarily reflect the official policies of the Department of Health and Human Services (HHS), nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

---

### HIV/AIDS Panel Agenda

###### Thursday| 7 March 2024 | DAY THREE

\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_

8:30-9:00 | Registration

9:00-9:10 | Announcements and Housekeeping

- Karl Salwedel, PhD, Division of AIDS, NIAID, NIH, USA

9:10-9:30 | Welcome form the AIDS Panel Chairs

- Akifumi Takaori-Kondo, MD, PhD, Kyoto University
- Thomas Hope, PhD, Northwestern University

9:30-10:00 | Novel Host Factors Regulating HIV-1 Latency

- Akifumi Takaori-Kondo, MD, PhD, Kyoto University

\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_

SESSION ONE: Data Science / AI and Emerging Technologies

10:00-10:30 | Mobilizing Integrated Organ Immunity Against HIV **|** Bali Pulendran, PhD, Stanford University

10:30-11:00 | Identification of Host Factors Regulating HIV-1 Latency and Their Potential Therapeutic Targets in HIV-1 Latency Reversal | Hiroaki Takeuchi, PhD, Tokyo Medical and Dental University

\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_

10:30-11:00 | Coffee Break 

\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_

11:00 - 11:30 | Distinctive Attributes of HIV-Infected CD4 T Cells under ART Revealed by Microfluidics-Assisted Sorting and Whole Transcriptome Sequencing | Eli Boritz, PhD, National Institute of Allergy and Infectious Diseases, NIH (virtual)

 

11:30 - 12:00 | Molecular profiling of the SIV tissue reservoirs microenvironment at a single focus level during ART and post-ATI | **Ramon Lorenzo-Redondo,** PhD, Northwestern University

12:00 - 12:30 | Characterization of the active HIV reservoir from ART-suppressed people with HIV | **Nadia Roan,** PhD, Gladstone Institutes; University of California, San Francisco (UCSF)

\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_

12:30-13:30 | Lunch Break

\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_

SESSION TWO: Viral Eradication and Control

1:30 - 2:00 | *In vitro* Studies for the Development of Drug-based Therapies for HIV Reservoirs | **Kenji Maeda, MD, PhD**, Kagoshima University

2:00 - 2:30 | The Role of SIV-specific follicular CD8 T Cells during Chronic SIV Infection | **Takuya Yamamoto, PhD**, National Institutes of Biomedical Innovation, Health and Nutrition

\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_

SESSION THREE: HIV Prevention Science

2:30 - 3:00 | Targeting Specificity of SIV-specific B-cell Responses | **Hiroyuki Yamamoto,** MD, PhD, National Institute of Infectious Diseases

3:00 - 3:30 | Beyond the Science: Going from Need to Impact with an HIV Vaccine **| Jerome Kim,** MD, International Vaccine Initiative, Seoul, South Korea

\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_

###### Friday| 8 March 2024 | DAY FOUR

\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_

8:30-9:00 | Registration

9:00-9:30 | Longitudinal PET scans provide novel insights into antibody biodistribution | **Thomas Hope,** PhD, Northwestern University 

\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_

SESSION FOUR: Clinical Virology and Pathogenesis

9:30 - 10:00 | Inspiration for HIV vaccine design from within-host HIV and antibody co-evolution| **Bette Korber,** PhD, Los Alamos National Laboratories (virtual)

 

10:00 - 10:30 | Defining Cellular Barriers to HIV infection through HIV-CRISPR Knockout Screening | **Molly Ohainle,** PhD, University of California, Berkeley

\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_

10:30-11:00 |Break

\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_

11:00 - 11:30 | High-level resistance to Integrase inhibitors conferred by mutations outside of Integrase **Yuta Hikichi, PhD**, National Cancer Institute, NIH

11:30 - 12:00 | HIV-Tocky System to Visualize Proviral Expression Dynamics **Yorifumi Satou, MD,** PhD, Kumamoto University

 

12:00 - 12:30 | Host ZCCHC3 Blocks HIV-1 Infection and Production by a Dual Mechanism **| Akatsuki Saito,** PhD, Miyazaki University

12:30-12:45 | Closing Remarks | Akifumi Takaori-Kondo, Thomas Hope

\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_

12:30-13:30 | Lunch Break

\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_

---

## If you have any questions or technical issues please contact Annie King, [aking@crdfglobal.org](mailto:aking@crdfglobal.org)

![](https://www.crdfglobal.org/wp-content/uploads/2021/12/crdf-logo-white.svg)

#### Advancing U.S. national security by mitigating threats and enhancing opportunities through technology, innovation, and collaboration.

### Let us know how we can help you reach your goals

[Facebook Facebook](https://www.facebook.com/CRDFGlobal) [Twitter](https://twitter.com/CRDFGlobal) [Instagram Instagram](https://www.instagram.com/crdfglobal/) [Linkedin Linkedin](https://www.linkedin.com/company/crdf-global)[Contact Us](https://insights.crdfglobal.org/contact-us?hsLang=en)

- WHO WE ARE 
    - [Our Story](https://crdfglobal.org/our-story/)
    - [Mission, Vision & Values](https://crdfglobal.org/mission-vision-values/)
    - [Leadership](https://insights.crdfglobal.org/leadership?hsLang=en)
    - [Our Experts](https://insights.crdfglobal.org/experts?hsLang=en)
    - [Partners](https://insights.crdfglobal.org/partners?hsLang=en)
- WHAT WE DO 
    - [Chemical, Biological & Nuclear Security](https://www.crdfglobal.org/what-we-do/cbrne-security-counterproliferation/)
    - [Cybersecurity & Digital Resilience](https://www.crdfglobal.org/what-we-do/cybersecurity/)
    - [Research, Data & Emerging Technology Security](https://www.crdfglobal.org/what-we-do/research-data-and-technology-security/)
    - [Security Cooperation & Exchanges](https://www.crdfglobal.org/what-we-do/international-exchanges/)
    - [Border Security & Strategic Trade Controls](https://www.crdfglobal.org/what-we-do/strategic-trade-border-security/)
    - [Health Security & Research](https://www.crdfglobal.org/what-we-do/global-health/)
- HOW WE DELIVER 
    - [Travel & Logistics](https://www.crdfglobal.org/capabilities/travel-logistics/)
    - [Security Strengthening](https://www.crdfglobal.org/capabilities/security-strengthening/)
    - [Fellowships & Exchanges](https://www.crdfglobal.org/capabilities/fellowships-and-exchanges/)
    - [Grants & Research Competitions](https://www.crdfglobal.org/capabilities/grants-research-competitions/)
    - [Technical & Professional Training](https://www.crdfglobal.org/capabilities/technical-and-professional-trainings/)
    - [Specialized Equipment Procurement](https://www.crdfglobal.org/capabilities/specialized-equipment-procurement/)
    - [Program Design and Management](https://www.crdfglobal.org/integrated-solutions/program-design-and-management/)
    - [Monitoring, Evaluation and Learning](https://www.crdfglobal.org/integrated-solutions/monitoring-evaluation-and-learning/)
    - [Remote Training & Learning](https://www.crdfglobal.org/integrated-solutions/remote-training-and-learning/)
    - [Quality Framework](https://www.crdfglobal.org/integrated-solutions/quality-framework/)
- COLLABORATE 
    - [Become a Partner](https://www.crdfglobal.org/become-a-partner/)
    - [Grants & Procurement](https://www.crdfglobal.org/grants-procurement/)
    - [Procurement & RFPs](https://insights.crdfglobal.org/rfp?hsLang=en)
    - [Funding & Grants](https://insights.crdfglobal.org/funding-opportunities?hsLang=en)
- [WHERE WE WORK](https://crdfglobal.org/where-we-work/) 
    - [NEWS & INSIGHTS](https://www.crdfglobal.org/news/)
    - [CAREERS](https://www.crdfglobal.org/careers/)

[Privacy Policy](https://www.crdfglobal.org/data-privacy-policy/)    [Code of Conduct](https://www.crdfglobal.org/participant-code-of-conduct/)

© 2026 CRDF Global - All rights reserved